Elsevier is the publisher of European Urology, the official journal of the European Association of Urology.
European Urology publishes peer-reviewed original articles and topical reviews on a wide range of urological problems. Topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, as well as recent advances in techniques, instrumentation, surgery and pediatric urology provide readers with a complete guide to international developments in urology.
Published monthly, European Urology is an important journal for all clinicians and researchers in this field.
All members of the EAU receive the journal as a benefit of their membership. For more information on the European Association of Urology, please go to: http://www.uroweb.orgSupplements to European Urology are published under the title European Urology Supplements(ISSN 1569-9056). This journal also incorporates the EAU-EBU Update Series (ISSN 1871-2592).
SKIP TO PARAGRAPH
European Urology – General Information
European Urology Focus
European Urology Oncology
European Urology Author Conduct Code
Authorship Criteria and Contributions and Authorship Form
Conflicts of Interest and Financial Disclosures
Privacy Protection and Informed Patient Consent
Data Sharing Policy
Ethical Considerations and Registration of Clinical Trials
Reporting of Research Using Animals
Statistical Analysis, Reporting and Interpretation
Surgery in motion
Case Series of the Month
Letters to the Editor
Words of Wisdom
Fast Track Articles
Residents Corner Articles
Manuscript Preparation and Submission Requirements
European Urology's 2018 impact factor is 17.298. The impact factor is a measure of the citation rate per article, and is calculated by dividing 1 year's worth of citations to a journal's articles published in the previous 2 years by the number of articles published by that journal in those 2 years. European Urology's acceptance rate is approximately 10% of the nearly 2000 solicited and unsolicited original manuscripts it receives annually; its average time from submission to first editorial decision is approximately 12 days.Each month European Urology publishes a wide variety of articles in all areas of urology and related sciences. The journal publishes review articles, original articles, Surgery in Motion articles with the accompanying video available online, editorials, editorial comments, interviews, debates, Words of Wisdom, Letters to the Editor, and case series.
Review articles, editorials and related articles, and letters to the editor can be read in full text at http://www.europeanurology.com and http://www.sciencedirect.com/science/journal/03022838.EU-ACME accredited questions are included in every issue of European Urology and can be answered at http://www.eu-acme.org/europeanurology.
Manuscripts should be submitted online via the European Urology online manuscript submission and review system at http://ees.elsevier.com/eururol.Statements in articles or opinions expressed by any contributor in any article are not the responsibility of the editors or the publishers. The publisher is not responsible for the loss of manuscripts through circumstances beyond its control.
Accepted manuscripts will be copyedited to make sure they conform to the journal's style. The final version of the manuscript following copyediting will be sent back to the author only if specific queries need clarification.English Language Standard
Authors whose native language is not English are expected to have their manuscripts proofread by a professional copyeditor of their choice before submission. Compuscript is the official copyeditor for European Urology.
Supplementary Files and Data
Information necessary for the article that is in excess of the manuscript restrictions, will be considered for on line publication or storage. Examples include extensive methodological descriptions, tables of data that are supplementary to the main article thread, details of reporting standards (such as CONSORT flow charts) and other useful figures. This information is to be submitted with the main manuscript and clearly labeled as Supplementary. It will be reviewed by the editorial office and peer reviewers to ensure that it is well presented in an acceptable format and that the contents are necessary. Please use the European Urology formatting style for references and presentation. There is no specific file name for Supplementary Material tables or figures. These may be uploaded under the file name table, figure or illustration.
European Urology Focus
European Urology Focus (EU Focus) is a sister journal to European Urology and an official publication of the European Association of Urology (EAU), a scientific society with more than 15,000 members from 120 countries worldwide. EU Focus is available online and reaches over 20,000 readers.EU Focus publishes original articles, case debates, clinical practice points, opinion piece editorials and topical reviews on all urological issues. The editorial team welcome basic and translational research articles in the field of urological diseases.
Authors may be solicited by the Editor directly, and may approach the editorial office for advice or guidance before submission.All submitted manuscripts are peer-reviewed by a panel of experts before being considered for publication.
EU Focus is published 6 times per year in electronic format. Each issue includes a series of invited themed reviews, together with original reports, correspondence and introductory Editorials.EU Focus articles are listed on the PubMed database.
Access to EU Focus articles is available through http://eufocus.europeanurology.com and http://www.sciencedirect.com/science/journal/24054569.Manuscripts should be submitted online via the European Urology Focus online manuscript submission and review system at http://ees.elsevier.com/eufocus. All author instructions for European Urology as outlined here also apply to European Urology Focus. There are four additional article types published in EU Focus. Specific instructions for these can be found at https://www.elsevier.com/journals/european-urology-focus/2405-4569/guide-for-authors.
The journal includes original articles, opinion piece editorials and invited reviews covering clinical, basic and translational research. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication. Original articles can be directly submitted to the journal via this link: http://ees.elsevier.com/euonco. In addition, selected manuscripts initially considered for publication in European Urology will be given the opportunity to be published in European Urology Oncology after completion of a fast and rigorous peer-review process. All author instructions for European Urology as outlined below equally apply to European Urology Oncology.
European Urology Author Conduct Code
European Urology recognizes the importance of publishing the highest quality manuscripts and making sure that all authors participate fully in each manuscript and do not conduct themselves in a manner that may be misleading or duplicitous. Authors who do not follow the journal’s authorship responsibility rules will be disciplined accordingly. The following statement outlines each author’s responsibilities and the potential penalties that can be applied under warranted circumstances.Author Responsibilities
The Corresponding Author is responsible for the completion and inclusion of the Authorship Responsibility, Financial Disclosure, and Acknowledgment Form. Submission of this form is an obligatory step of the submission process for Original Articles, Review Articles, and Surgery in Motion articles. A standard disclosure stating conflicts of interests, if any, can be uploaded for letters to the editor, editorials, Words of Wisdom, and case reports. If the disclosure form is not completed as instructed, the manuscript may not be considered for peer review and will not be published until completed. This form, along with a complete explanation of the role of the Corresponding Author, can be found in the Resources for Authors section of http://www.europeanurology.com.
Definition of Author Misconduct
European Urology will follow the definitions of Author Misconduct that are currently used by the National Library of Medicine (NLM) and will apply the relative penalties also as outlined by the NLM at http://www.nlm.nih.gov/pubs/factsheets.
- Errata. Published changes or emendations to an earlier article, frequently referred to as “corrections” or “corrigenda,” are considered by the NLM to be errata, regardless of the nature or origin of the error. The NLM does not differentiate between errors that originated in the publication process and errors of logic or methodology.
- Retractions. Retractions identify a citation that was previously published and is now retracted through a formal issuance from the author, publisher, or other authorized agent. The NLM does not differentiate between articles that are retracted because of honest error and those that are retracted because of scientific misconduct or plagiarism. If the notification in the journal is labeled as a retraction or withdrawal, NLM will index it as a retraction.
- Expressions of Concern. This indexing term was introduced by the International Committee of Medical Journal Editors and incorporated into the NLM system in 2004. The expression of concern is a label that an editor may use to draw attention to possible problems, but it does not go so far as to retract or correct an article. Examples of this correction format are provided at the end of this section.
Potential Author Misconduct may arise from both submitted manuscripts and published articles. Definitions of misconduct can be seen as follows:
- Plagiarism, or attempting to use another’s work as one’s own
- Fabrication or falsification of data (including deliberate misrepresentation of results and their implications)
- Publication of content that corresponds substantially with previously printed or electronically published content without recognition, referencing, and explanation of this overlap and the advances of the current work
- Failure to reference a contributing author or removing an author without written consent from the author in question and the contributing co-authors
- Inappropriately giving credit to an author who did not contribute to the drafting, revision, or supervision of the article and therefore does not meet the authorship requirements as stated in the Authorship Responsibility, Financial Disclosure, and Acknowledgment Form.
- Failure to disclose relationships in accordance with the European Urology Conflict of Interest Policy, as listed in the Resources for Authors at http://www.europeanurology.com
Journal Response to Potential Author Misconduct
Once the Editor and/or the Publisher has been informed of possible author misconduct, a thorough internal investigation will be carried out to determine whether or not and to what degree an author has breached the responsibility contract. misconduct has been determined, the Editor will contact the author to discuss the concern and explain the determined consequences according to the NLM. If the author refuses to comment or respond to the allegation of misconduct, that same author will assume responsibility with no further discussion.
If instead, at any point during the journal’s investigation, an author admits to misconduct or provides a satisfactory explanation, the journal will conclude its investigation and consider appropriate actions to take.
If misconduct is verified or admitted, the journal may apply an appropriate penalty against the author(s) at the discretion of the Editor-in-Chief and the publisher. The level and length of the penalties may vary depending on the severity of the misconduct and whether the manuscript in question was submitted or published. Authors will be notified in writing.
Examples of possible punishment may include but are not limited to:
- Letter of reprimand to the author(s) of a submitted or published manuscript;
- Notice to the author’s institution and/or the institution where the research was conducted;
- Restriction of the author(s) publishing in European Urology for a specified period of time.
- European Urology reserves the right to reject a submitted manuscript and to retract or publish an erratum or statement of concern about a published article, as appropriate.
- European Urology reserves the right to inform Editors and Publishers of peer-reviewed journals publishing in similar or identical fields.
European Urology also follows ICMJE's Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals: http://www.icmje.org/recommendations/
Authorship Criteria and Contributions and Authorship Form
Completion and inclusion of the Authorship Responsibility, Financial Disclosure and Acknowledgment Form is an obligatory step of the submission process for Original Articles, Review Articles and Surgery in Motion articles. A standard disclosure stating conflicts of interests, if any, can be uploaded for letters to the editor, editorials, words of wisdom and case reports.If the form is not completed as instructed below, the manuscript will not be considered for peer review.
The corresponding author must submit the above mentioned completed form on behalf of all co-authors, if any. Download form here: authorship form.The corresponding author must take responsibility for the integrity of the work as a whole, from inception to published article. Each collaborating author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Authorship credit should be based on: substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting of the article or revising it critically for important intellectual content, statistical analysis, obtaining funding, administrative, technical or material support, supervision and any other specifics to be declared at publication. The corresponding author is obliged to indicate the co-authors contribution to the manuscript in the appropriate field in the said form. Each co-author's specific contribution for reports of original data and systematic reviews will be included with the published manuscript.
Each field may include more than one author.Role of the Corresponding Author
The corresponding author will serve on behalf of all co-authors as the primary correspondent with the editorial office during the submission and review process. If the manuscript is accepted, the corresponding author will review an edited typescript and proof and will be identified as the corresponding author in the published article. The corresponding author is responsible for ensuring that all information included in the Authorship Responsibility, Financial Disclosure and Funding Support form and the Acknowledgment section, if any, is complete and has been agreed on by all authors. ''Acknowledgment'' is the general term for the list of contributions, credits, and other information included at the end of the text of a manuscript before the references.
If authorship is attributed to a group (either solely or in addition to one or more individual authors), all members of the group must meet the full criteria and requirements for authorship as described above. If that is not the case, a group must designate one or more individuals as authors or members of a writing group who meet full authorship criteria and requirements. Other group members who are not authors may be listed in an Acknowledgment.
Declaration of Interest and Financial Disclosures
A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author's decisions, work, or manuscript.Authors are expected to provide detailed information about all relevant financial interests and relationships or financial conflicts (e.g., employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), particularly those present at the time the research was conducted and through publication, as well as other financial interests (such as patent applications in preparation), that represent potential future financial gain.
For example, authors of a manuscript about prostate cancer should report all financial relationships they have with all manufacturers of products used in the management of prostate cancer, not only those relationships with companies whose specific products are mentioned in the manuscript.Although many universities and other institutions have established policies and thresholds for reporting financial interests and other conflicts of interest, European Urology requires complete disclosure of all relevant financial relationships and potential financial conflicts of interest, regardless of amount or value. Downloads: authorship form.
"Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published.Complete anonymity is difficult to achieve, and informed consent for publication should be obtained if there is any doubt. If data are changed to protect anonymity, authors should provide assurance that alterations of the data do not distort scientific meaning.
When informed consent has been obtained it should be indicated in the published article."For papers that include information or images which could identify or potentially identify individuals, then authors must provide evidence of a proper consent form which the patient, parent or guardian has signed acknowledging the potential of publication and their awareness of the content. They should be informed about Elsevier publishing policy, in which images and text will be published online and in print and are available for any lawful purpose. The signed consent form should be filed securely in the patient's case notes and the article submitted to European Urology should include this statement indicating that specific consent for publication was obtained: "The patients in this manuscript have given written informed consent to publication of their case details.” The Editorial office will not store or collect consent forms, but reserves the right to enquire about or audit their presence, through proper and legal means.
All disclosures of any potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript will be disclosed by the corresponding author on behalf of each co-author, if any, as part of the submission process. Likewise, authors without conflicts of interest, will be requested to state so as part of the submission process.If authors are uncertain about what constitutes a relevant financial interest or relationship, they should contact the editorial office.
Failure to include this information in the manuscript will prohibit commencement of the review process of the manuscript.For all accepted manuscripts, each author's disclosures of conflicts of interest and relevant financial interests and affiliations and declarations of no such interests will be published.
The policy requesting disclosure of conflicts of interest applies for all manuscript submissions. If an author's disclosure of potential conflicts of interest is determined to be inaccurate or incomplete after publication, a correction will be published to rectify the original published disclosure statement.Authors are also required to report detailed information regarding all financial and material support for the research and work, including but not limited to grant support, funding sources, and provision of equipment and supplies as part of the submission process. For all accepted manuscripts, each author's source of funding will be published.
Funding/Support and Role of Sponsor
All financial and material support for the research and work will be requested to be clearly and completely identified as part of the submission process. The specific role of the funding organization or sponsor in each of the following should be specified: ''design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.'' The corresponding author is responsible for acknowledging this on the authorship form at the time of submission.
For all reports (regardless of funding source) containing original data, at least one named author (e.g., the principal investigator) who is independent of any commercial funder should indicate that she or he ''had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.'' This exact statement will be requested as part of the submission process. Modified statements or generic statements indicating that all authors had such access are not acceptable.
For authors reporting molecular results derived using high throughput technologies we support the use of minimum reporting standards. For example, for microarrays we support the use of the MIAME 2.0 standards, for deep sequencing we support MIN-Seq and for realtime PCR we support the MICQ guidelines. Details of these are available at http://www.mged.org/index.html or http://miqe.gene-quantification.info/. We require that datasets derived from these experiments and used for reports within European Urology are deposited on line at the appropriate repositories, such as ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) or GEO, NCBI (http://www.ncbi.nlm.nih.gov/geo/).Duplicate/Previous Publication or Submission
Duplicate/Previous Publication or SubmissionManuscripts are considered with the understanding that they have not been published previously in print or electronic format and are not under consideration by another publication or electronic medium. Copies of related or possibly duplicative materials (ie, those containing substantially similar content or using the same or similar data) that have been previously published or are under consideration elsewhere must be provided at the time of manuscript submission. Publication of the work at an scientific meeting, in abstract form or on a pre-print server that does not conflict with submission to European Urology is allowed but should be disclosed at submission.
Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, formal review and approval, or review and waiver, by an appropriate institutional review board or ethics committee is required and should be described in the Methods section. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. For investigations of human subjects, state in the Methods section the manner in which informed consent was obtained from the study participants (ie, oral or written).
A signed statement of permission should be included from each individual identified as a source of information in a personal communication or as a source for unpublished data, and the date of communication and whether the communication was written or oral should be specified.
Previous Presentation or Release of Information
A complete report following presentation at a meeting or publication of preliminary findings elsewhere (e.g., an abstract) is eligible for consideration for publication.
Published manuscripts become the permanent property of the EAU and may not be published elsewhere in whole or in part without written permission. Unauthorized use of the European Urology name, logo, or any content for commercial purposes or to promote commercial goods and services (in any format, including print, video, audio, and digital) is not permitted by the EAU.
Editorial Review and Publication
Authors will be sent notifications of the receipt of manuscripts and editorial decisions by e-mail. During the review process, authors can check the status of their submitted manuscript via the online manuscript submission and review system.
All submitted manuscripts are reviewed initially by the European Urology Editor-in-Chief and Associate Editors. Manuscripts submitted for the Surgery in Motion section will also undergo peer review, supervised by the Editor-in-Chief and the Surgery Editor and must be submitted along with the accompanying video (please see ''Types of Articles'' section below).
Manuscripts are evaluated according to the following criteria: material is original and timely, writing is clear, study methods are appropriate, data are valid, conclusions are reasonable and supported by the data, information is important, and the topic has general interest for urologists. From these basic criteria, the editors decide whether a manuscript reaches a priority score to justify peer review. Manuscripts with insufficient priority for publication are rejected promptly. Manuscripts which have not be straight rejected are sent to expert consultants for peer review. Although rare, it is possible for an exceptional manuscript to be accepted upon submission.Reviewers are matched to the paper according to their expertise. Our reviewer database is constantly being updated to ensure the reviewer profile matches that of the topic being discussed in the manuscript. We welcome suggestions for reviewers from the author though these recommendations may or may not be considered.
Manuscripts considered to be of interest by the editors will be peer reviewed by internationally recognized experts on the subject. Each manuscript is sent to 3–8 reviewers. Most papers are also peer reviewed by a statistical editor. A copy of the study protocol may be requested during the review process.Data Sharing
We expect authors to freeze datasets at the time of publication and to keep copies of this frozen data for up to 5 years. If the dataset continues to increase, we request that authors maintain the copied, frozen original data necessary for publication. We expect that anonymised versions of this dataset are made available upon request from the editorial office, if necessary, for methodological review or data validation. Although we will not keep store such data. We also encourage that anonymised data are made available following reasonable requests by other authors or investigators. We recognize that legal requirements differ between countries and respect those obligations for the submitting authors.Data Sharing Policy
- 1. Researchers need to include a data sharing statement:
- a. Data are freely available at a data archive (include web address)
- b. Data are available for bona fide researchers who request it from the authors
- c. Data are not available to other researchers
- 2. Option c (data not available to other researchers) is not available for human clinical trials (experimental treatment) without prior agreement of the editors.
- 3. If data are not available to other researchers, then authors need to give a reason:
- a. Publicly available data
- b. Vulnerable population
- c. Registry or institutional database of patients providing routinely collected data
- d. Other
- 4. Preparation of this paper did not involve analysis of data.
Trial Registration: As a member of the International Committee of Medical Journal Editors (ICMJE), European Urology requires, as a condition of consideration for publication, registration of all trials in a public trials registry that is acceptable to the ICMJE and that requires the minimum registration data set as described by the ICMJE.Acceptable trial registries include the following:
All Randomized Controlled Trials require proof of protocol. Authors are expected to provide relevant protocol information upon request. Authors who would not able to provide this information should contact the Editorial Office upon submission.CONSORT Flow Diagram and Checklist: Manuscripts reporting the results of randomized controlled trials should include the CONSORT flow diagram showing the progress of patients throughout the trial. The CONSORT checklist also should be completed and submitted with the manuscript and can be found on http://www.consort-statement.org/consort-statement/checklist.
Biomarkers: European Urology encourages manuscripts reporting biomarkers and biological markers to adhere to the REMARK reporting criteria. Please refer to REMARK guidelines.Reporting of Research Using Animals
European Urology asks authors to refer to the ARRIVE guidelines when reporting research were animals were involved.
Access the ARRIVE guidelines here.
On the grounds that the conclusions of many papers depend critically on the statistical analysis, and that it has been amply demonstrated that statistical deficiencies are common in the medical literature, European Urology pays particular attention to statistical aspects of submitted papers. Authors are advised to check our statistical guidelines Guidelines for Reporting of Statistics in European Urology and should note that most papers are peer reviewed by a professional statistician, often a member of the editorial board.Submission of statistical code
There is a strong consensus amongst statisticians that fully annotated and high quality programming code is essential for implementing accurate and reproducible statistical analyses. But it is also widely accepted that for many papers published in the biomedical literature, such code is either poor quality or even missing altogether.
Calls for the publication of statistical code, as well as raw data, alongside research results are based on the rationale that such publication clearly aids attempts at replication, a key criterion of science. But it has also been argued that publication of code and data would also improve the scientific process: where researchers know that their code and data will be reviewed by their peers, they are more likely to write better code and make sure that their data are clean and accurate.
European Urology has therefore implemented the following policies:
- All authors are asked to submit statistical analysis code at the time that their research paper is accepted for publication.
- Authors have three choices:
a. State that no or only trivial code was used in the analyses
b. Decline to provide code
c. Submit their analytic code
- The authors' choice is published alongside author contributions, funding and so on.
- If authors decide to submit code, it is entirely up to them what code they submit. For instance, they may decide to submit only the code used for a subset of key analyses, or a more complete set of code, including code used to clean the data set and prepare it for analysis.
- We do not expect that preparing code for archiving should take more than a few minutes, in terms of choosing the subset of programming files to submit and perhaps writing a brief "README.TXT" document explaining features such as user-written macros.
- Code submitted by authors is archived by the journal, to be released on reasonable request by any interested party.
- Is original
- Is methodologically sound
- Follows appropriate ethical guidelines
- Has results that are clearly presented and support the conclusions
- Correctly references previous relevant work
- Is aimed at the journal's target readership
Reviewers are not expected to correct or copyedit manuscripts. Language correction is not part of the peer-review process.Reviewers are allotted 10 days to complete their reviews. The reviewers are not blinded to the names of the authors or the institution from which the manuscripts have been submitted.
The final decision to accept, revise, or reject a manuscript is made by the Editor-in-Chief after carefully considering the opinion of the Associate Editor(s) handling that particular manuscript. The decision is sent to the author along with any recommendations made by the reviewers and editors.
Prior to submitting a manuscript to European Urology, authors must ensure that each requirement listed below is met. Manuscripts that do not meet these requirements will be returned to the author without review.
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright, see http://www.elsevier.com/copyright. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.Editing
Accepted manuscripts are edited in accordance with the journal in-house style which is based on American Medical Association (AMA) style. Authors are expected to be responsible for all statements made in their work, including changes made during editing and production that are authorized by the corresponding author.
Requests to publish corrections should be sent to the editorial office. Corrections are reviewed by editors and authors, published promptly, and linked online to the original article. Offprints
Offprints may be ordered when the edited typescript is sent for approval to the corresponding author. Additional copies (minimum 100) can be ordered at prices quoted on the order form that will be sent with the acknowledgment letter.
Although cover letters are not mandatory for submission, authors wishing to include a cover letter with their manuscript are welcome to submit a letter either as a separate file or as part of the manuscript file. Please note that manuscript files containing a cover letter will be available for reviewers to view if the manuscript is sent for peer review. If the authors prefer to submit a letter for the Editor(s) consideration only, please include the text of the letter in the "enter comments" step of the electronic submission process.Article Types
Each manuscript should clearly state an objective or hypothesis; the design and methods (including the study setting and dates, patients or participants with inclusion and exclusion criteria and/or participation or response rates, or data sources, and how these were selected for the study); the essential features of any interventions; the main outcome measures; the main results of the study; a discussion section placing the results in context with the published literature and addressing study limitations; and the conclusions. Data included in research reports should be as timely and current as possible.We encourage authors to report outcomes and complications in a structured manner. We advise the use of peer reviewed documents to guide this such as Mitropoulous et al, Reporting and Grading of Complications After Urologic Surgical Procedures: An ad hoc EAU Guidelines Panel Assessment and Recommendations or other recognized reporting structures.
The text of the manuscript should be divided as follows: Introduction; Material (Patients) and Methods; Results; Discussion; Conclusions.
Maximum word count is 2800, including the abstract but not including the references, tables, figures, or legends. (Abstract maximum 300 words; Text maximum 2500 words).Take Home Message
Two or three sentences (no more than 40 words) summarizing the main message expressed in the article must be uploaded as a separate file. Downloads: Original Article Abstract
The format of the original article should be as follows:Provide a structured abstract no longer than 300 words with the following sections: Background; Objective; Design, Setting, and Participants; Intervention (include if there are any); Outcome Measurements and Statistical Analysis; Results and Limitation; Conclusions and Patient Summary (The Patient Summary is an obligatory section of the manuscript. Submissions not including the patient summary will be returned to the corresponding author).
Original Articles must be no longer than 2800 words (300 abstract + 2500 body not including the reference list, tables, figures or legend). References are limited to 30. Please limit tables and figures to 6. Additional tables, figures or appendices may be submitted as supplementary material but will be published online only.For brevity, parts of the abstract may be written as phrases rather than complete sentences. Each section should include the following content (see abstract structure details below):
- Background: The abstract should begin with a sentence or two explaining the clinical (or other) importance of the study question.
- Objective: State the precise objective or study question addressed in the manuscript (e.g., ''To determine whether. . .''). If more than one objective is addressed, the main objective should be indicated and only key secondary objectives stated.
- Design, Setting, and Participants: Describe the basic design of the study. State the years of the study and the duration of follow-up. Describe the study setting to assist readers to determine the applicability of the report to other circumstances, for example, general community, a primary care or referral center, private or institutional practice, or ambulatory or hospitalized care. State the clinical disorders, important eligibility criteria, and key sociodemographic features of patients. The numbers of participants and how they were selected should be provided. In follow-up studies, the proportion of participants who completed the study must be indicated. In intervention studies, the number of patients withdrawn because of adverse effects should be given. For selection procedures, these terms should be used, if appropriate: random sample (where random refers to a formal, randomized selection in which all eligible individuals have a fixed and usually equal chance of selection); population-based sample; referred sample; consecutive sample; volunteer sample; convenience sample.
- Intervention(s): The essential features of any interventions (surgical or medical) should be described. The nonproprietary drug or device names should be used unless the specific trade name is essential to the study.
- Outcome Measurements and Statistical Analysis: Indicate the primary and secondary study outcome measurement(s) and the main statistical analysis.
- Results and Limitations: The main outcomes of the study should be reported and quantified. Complications or sequelae of the interventions used must be detailed. Particular attention must be paid to estimates of treatment effect and confidence intervals and not just to p-values. All randomized controlled trials should include the results of intention-to-treat analysis, and all surveys should include response rates. Limitations of the study should be acknowledged.
- Conclusions: Provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralization. Indicate whether additional studies are required before the results should be used in usual clinical settings. Give equal emphasis to positive and negative findings of equal scientific merit.
- Patient summary: Please include at the end of the abstract 2-3 short sentences in plain english to describe your findings to a non-medical audience. For example: " In this report we looked at the outcomes from invasive bladder cancer in a large European population. We found that outcomes varied with patient age and treating centre. We conclude that the best outcomes are seen in younger patients treated at high volume hospitals. You will also be asked to include this summary in the "Additional Information" section of the submission process.
Please note that if your study is animal based, the patient summary should state how you anticipate the results of your study would affect a patient population.Review Articles
European Urology aims at publishing mainly systematic reviews (and meta-analyses, whenever appropriate). These are reviews that systematically find, select, critique, and synthesize evidence relevant to well defined questions about diagnosis, therapy, and prognosis. Manuscripts reporting systematic review and meta-analysis should comply with the PRISMA statement. Such review articles are in principle solicited by the editorial board. Authors who would like to submit unsolicited systematic review articles should first write to the editorial office describing the content of the review article they wish to submit. Review articles should not be submitted in full without prior approval from the editors.If you are interested in submitted a review article, please use the following form to send an outline and structured abstract with the following information to the Editorial Office:
1). Title and Author list2). Systematic Review Search criteria and the preliminary results of this search (including an estimate of how many manuscripts will be included for analysis)
3). Primary and secondary outcomes that will be reported (including likely number of persons used to report these data)4). Null hypothesis and likely conclusions
The format of the review article should be as follows:Abstract: Provide a structured abstract no longer than 300 words with the following sections: Context, Objective, Evidence Acquisition, Evidence Synthesis, Conclusion and Patient Summary.
Review Articles must be no longer than 4000 words (300 abstract + 3700 body not including the reference list, tables, figures or legend). References are limited to 50. Please limit tables and figures to 6. Additional tables, figures or appendices may be submitted as supplementary material but will be published online only.Downloads: Review Article Abstract Example
Context: Include one or two sentences describing the clinical question or issue and its importance in clinical practice or public health.Objective: State the precise primary objective of the review. Indicate whether the review emphasizes factors such as cause, diagnosis, prognosis, therapy, or prevention and include information about the specific population, intervention, exposure, and tests or outcomes that are being reviewed.
Evidence Acquisition: Describe the data sources used, including the search strategies, years searched, and other sources of material, such as subsequent reference searches of retrieved articles. Methods used for quality assessment and inclusion of identified articles should be explained.Evidence Synthesis: The major findings of the review of the clinical issue or topic should be addressed in an evidence-based, objective, and balanced fashion, with the highest quality evidence available receiving the greatest emphasis.
Conclusions: The conclusions should clearly answer the questions posed if applicable, be based on available evidence, and emphasize how clinicians should apply current knowledge.Patient Summary: Please include at the end of the abstract 2-3 short sentences in plain English to describe your findings to a non-medical audience. For example: " In this report we looked at the outcomes from invasive bladder cancer in a large European population. We found that outcomes varied with patient age and treating centre. We conclude that the best outcomes are seen in younger patients treated at high volume hospitals. " You will also be asked to include this summary in the "Additional Information" section of the submission process.
The text of the manuscript should be divided as follows: Introduction, Evidence Acquisition, Evidence Synthesis, Conclusions.
Maximum word count is 4000, including the abstract but not including the references, tables, figures, or legends.Number of references should be limited to 50.Please note that a maximum of 6 tables and/or figures total will be published with the article. Additional figures and tables will be available as supplementary material online only.
Take Home Message
Two or three sentences (no more than 40 words) summarizing the main message expressed in the article must be uploaded as a separate file.
Authors are welcome to submit manuscripts describing particular surgical techniques. In addition to describing the technique in detail, early and long term results and complications must be reported as well. Mandatory requirements include a minimum number of 10 patients who have undergone the procedure in discussion and with a minimum 1-year follow-up of all patients. As this is an illustrative and demonstrative section of the journal, preference will be given to manuscripts which include illustrative images and sketches. Authors are encouraged to include professional sketches describing the key steps of the surgical procedures. If you need assistance finding an artist, please contact the Editorial Office at firstname.lastname@example.org. Examples of suitable sketches can be found here.The same preference is given towards videos which include high quality, well edited clips and images. European Urology will not provide editing services but suggests authors in need of assistance to contact MediAVentures http://www.mediaventures.be/.
In order to be considered eligible for the Surgery in Motion section, each manuscript must be accompanied by an explanatory video which includes narration of the surgical procedure. Please ensure you upload the video files in mp4 format no bigger than 150MB with the manuscript files in the EES System. When uploading, the video file is to be listed under the "video" description tag. If the system will not accept your file or you have any questions or concerns, please contact the Editorial Office at email@example.com.A second option is to send your video (max 150 MB) via WeTransfer. If you are not familiar with this service, please visit https://www.wetransfer.com/howitworks .
The format of these manuscripts should follow the guidelines for original articles with the exception of the abstract.Abstract
Provide a structured abstract no longer than 300 words with the following sections: Background; Objective; Design, Setting, and Participants; Surgical Procedure; Measurements; Results and Limitations; Conclusions and Patient Summary.For brevity, parts of the abstract may be written as phrases rather than complete sentences.
- Background: The abstract should begin with a sentence or two explaining the importance of and the need for the described surgical procedure.
- Objective: State the precise objective addressed in the manuscript (e.g., ''To show the efficacy and safety of . . .'').
- Design, Setting, and Participants: Describe the basic design of the study. State the years of the study and the duration of follow-up. Describe the study setting to assist readers to determine the applicability of the report to other circumstances, for example, office-based/private urologists vs. hospital/academic urologists. State the number, clinical characteristics, and important inclusion/ exclusion criteria of patients.
- Surgical Procedure: The essential features of the operation should be described. The nonproprietary device names should be used unless the specific trade name is essential to the study.
- Measurements: Indicate the primary and secondary study outcome measurement(s).
- Results and Limitations: The main outcomes of the study should be reported and quantified.
- Complications or sequelae of the procedure used must be detailed. Limitations of the study must be acknowledged.
- Conclusions: Provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralization. Indicate whether additional study is required before the information should be used in usual clinical settings.
- Patient Summary: Please include at the end of the abstract 2-3 short sentences in plain English to describe your findings to a non-medical audience. For example: "In this report we looked at the outcomes from invasive bladder cancer in a large European population. We found that outcomes varied with patient age and treating centre. We conclude that the best outcomes are seen in younger patients treated at high volume hospitals."
- You will also be asked to include this summary in the "Additional Information" section of the submission process.
- Give equal emphasis to positive and negative findings of equal scientific merit.
- Examples of how a Surgery in Motion abstract should be structure
Please note that we no longer consider single case studies.This section is dedicated to publishing promising studies which have only preliminary results at this stage.
We ask that your Case Series reports on no more than 10 patients and include illustrative images.The Case Series should be as follows: an unstructured abstract of no more than 200 words, the case series, the discussion and a maximum of 10 references. The text must be accompanied by 4 to 6 figures or photos which will be published on the front cover of the journal. The 1500 word count limit includes the abstract and the body but not the figures, tables, legends or references.
Please also include a CME question with 4 multiple choice answers. The question will be published at the end of the article and made available on our dedicated CME website. The questions and answers will not be published in the same issue but will be available on http://www.eu-acme.org/europeanurology/.Editorials
Platinum Priority Editorials
These are invited commentaries on current topics or on papers published elsewhere in the issue. Word count limit is 1000 and 10 references are allowed. Please limit illustrations (figures or tables) to 1. We kindly ask that the number of authors be limited to no more than 3. We will allow supplementary material to be submitted and reviewed, however, this material will be available online only if accepted.All editorials are solicited by the editors and should not be submitted without prior written approval. The editorial should include a link to the related manuscript with a phrase such as "Within this issue of European Urology, Smith et al . . ." The editorial should briefly review the findings, highlight good and bad points of the work and set the place of this work within the scientific community. The most interesting editorials are opinionated but balanced. The authors are given the right of a brief (less than 500 words) reply to most Platinum Priority Editorials.
These may be submitted or invited by the editorial board. The editorial office should be contacted prior to submission to obtain approval for unsolicited work. Platinum Opinion Editorials are stand alone opinion pieces that discuss an important and contemporary element of urological care. They should highlight current problems with urological care and identify potential solutions. Word count limit is 1000 and 10 references are allowed.We kindly ask that the number of authors be limited to no more than 3. We will allow supplementary material to be submitted and reviewed, however, this material will be available online only if accepted.
The format of the Platinum Opinion Editorial has no abstract. The main report is unstructured and should lead the reader from the concept through completion and a conclusion of the work. The manuscript count is limited to 1000 words (excluding references and legends), 2 figures or tables and 10 references. Supplementary online content is welcomed for this work and is likely to be necessary.Platinum Opinion Editorials require a 2 or 3 sentence take home message (no more than 40 words) summarizing the main message expressed in the article must be uploaded as a separate file. http://ees.elsevier.com/eururol/.
Please note that European Urology considers two different types of Letters to the Editor:1) Letters to the Editor about a recent journal article
Letters referring to a recent journal article must be received within three months of its publication. For example, a letter referring to an article published in the January issue must be submitted online no later than March 31st. Letters submitted after the allowed time will not be considered. The text, not including references, must not exceed 500 words. A maximum of three authors and five references are allowed. Neither tables nor figures are allowed.
2) Research Letters
Original research that is of interest but does not fulfill all the requirements needed for publication as a full-length manuscript can be submitted as a letter to the editor. There is no limit to the number of authors but the letter must have a title and can include a figure.
The format of the manuscript is of an unstructured abstract (up to 200 words) that should introduce and briefly summarize the work and also include a patient summary(2-3 short sentences in plain English to describe your findings to a non-medical audience. For example: "In this report we looked at the outcomes from invasive bladder cancer in a large European population. We found that outcomes varied with patient age and treating centre. We conclude that the best outcomes are seen in younger patients treated at high volume hospitals.").The main report is also unstructured but should lead the reader from the concept through completion and a conclusion of the work. The manuscript count is limited to 1000 words (excluding abstract, references and legends), 2 figures or tables and 10 references. Supplementary online content is welcomed for this work and is likely to be necessary.
Brief Correspondence also require a 2 or 3 sentence take home message (no more than 40 words) summarizing the main message expressed in the article must be uploaded as a separate file.Words of Wisdom
The Words of Wisdom contributions are by invitation only. If you are interested in submitted a piece for consideration in this section, please contact the Editorial Office.Fast Track Articles
For new findings of sufficient importance to justify accelerated review and publication, a fast-track submission process for original articles is available. In the “comments” section of the submission process, authors should explicitly request this option. If the editors agree that the manuscript is worthy of fast-track publication, the authors will receive an invoice for €1000 with payment instructions from Elsevier. If accepted for fast-track submission, an article will be reviewed within 72 hours (otherwise, authors will be informed that the paper will be handled within the normal peer-review process). If accepted, a fast-track submission will appear in the first available issue of the journal. Please note that payment for the Fast Track process is applied regardless of the final decision after peer review.Residents Corner Articles
This section is reserved for original articles for which the first author is a resident in training or fellow. Authors should provide official certification of resident or fellow status when submitting an article for this specific section of the journal. This certification can be in the form of a letter on official institution letterhead signed by the head of the department and uploaded as an additional file with the manuscript.Manuscripts must adhere to the instructions for author for Original Articles (see above).
The two best papers published in this section during the calendar year will be awarded a special prize during the European Urological Association annual meeting.Open Access
This journal offers authors a choice in publishing their research Open Access. Articles are freely available to both subscribers and the wider public with permitted reuse. An open access publication fee is payable by authors or on their behalf e.g. by their research funder or institution.Regardless of how you choose to publish your article, the journal will apply the same peer review criteria and acceptance standards.
The Open Access fee for this journal is $5000, excluding taxes. Learn more about Elsevier's pricing policy at http://www.elsevier.com/openaccesspricing.Elsevier has established a number of agreements with funding bodies which allow authors to comply with their funder's open access policies. Some authors may also be reimbursed for associated publication fees. To learn more about existing agreements please visit http://www.elsevier.com/fundingbodiesg.
After acceptance, open access papers will be published under a noncommercial license. For authors requiring a commercial CC BY license, you can apply after your manuscript is accepted for publication.For more information please visit http://www.elsevier.com/about/open-access.
European Urology follows the EQUATOR network resource centre guidance on good research reporting (http://www.equator-network.org/). Click here for a list of useful reporting guideline websites which European Urology recommends.
Manuscripts should be written in English. Authors are free to choose between British English and American English in terms of spelling and grammar as long as the language style is consistent throughout the text.
Include a title page, abstract, text, references, and as appropriate, figure legends, tables, and figures, take home message (for original and review articles) and authorship form (the authorship form can be downloaded here).
Manuscript File Formats
For submission and review, acceptable manuscript file formats include Word, WordPerfect, EPS, Text, Postscript, or RTF format. Use 12-point font size, double-space text, and leave right margins unjustified with margins of at least 2.5 cm. Each page should be numbered in the upper right corner, beginning on p. 2. Add continuous line numbering.
The title page should include a word count for the text and abstract separately. Authors full names, highest academic degrees, and affiliations should also be included (see list below). If an author's affiliation has changed since the work was done, the new affiliation also should be listed. For indexing purposes, 3-10 keywords should be supplied in alphabetical order (see example below).
- Authors (first name and initials followed by surname, e.g., Juan X. Alvarez)
- Affiliations (if multiple affiliations are listed, indicate with lowercase letter footnotes following the respective authors names)
- Contact information for corresponding author, including full mailing address, telephone number, fax number, and e-mail address
- For indexing purposes, 3-10 keywords should be supplied (in alphabetical order) as follows:
Keywords Benign prostatic hyperplasia; Doxazosin; Lower urinary tract symptoms
Word count of text: include the abstract but not the references in this count
Word count of the abstract (please remember Abstracts cannot exceed 300 words)
Include a structured abstract of no more than 300 words for original, review and surgery in motion articles. (See instructions above for preparing structured abstracts.) Abstracts are not required for editorials. No information should be reported in the abstract that does not appear in the text of the manuscript.
Do not use automatically generated numbering or bulleting systems or hidden text (e.g., for headings, references, footnotes, lists).
Units of Measurement
Units of measurements must conform to the Systeme International (SI): year(s), yr; month(s), mo; days, d; hours, h; minutes, min; seconds, s; grams, g; liters, l; meters, m; sample size, n; degrees of freedom, df; standard error of the mean, SE; standard deviation, SD; probability, p.
Use numerals for all values greater than ten and those followed by a unit; otherwise, spell out (e.g., 18 patients, 0.8 g/ml, 47%, 37°C, six cases). Spell out numbers at the beginning of a sentence. Abbreviations must be defined at first use in each of the following: text, tables, and figure legends.
Larger or more complex tables can be made available online as supplemental material.It is impossible to further stipulate exact table size or content, but consider using supplementary on line table for large datasets or those that may be unsuitable/too large for publication on one journal page.
Example: Rassweiler JJ, Knoll T, Köhrmann KU, et al. Shock wave technology and application: an update. Eur Urol 2011;59:784–96.
Data referencesThis journal encourages you to cite underlying or relevant datasets in your manuscript by citing them in your text and including a data reference in your Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. This identifier will not appear in your published article.
An example of how such a reference should look: Oguro M, Imahiro S, Saito S, Nakashizuka T. Mortality data for Japanese oak wilt disease and surrounding forest compositions, Mendeley Data, v1; 2015. http://dx.doi.org/10.17632/xwj98nb39r.1.http://www.eu-acme.org/europeanurology/.